UBS AM’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.28M Buy
38,571
+7,010
+22% +$564K ﹤0.01% 1825
2026
Q1
$2.38M Buy
31,561
+4,612
+17% +$339K ﹤0.01% 1953
2025
Q4
$1.83M Buy
26,949
+6,451
+31% +$403K ﹤0.01% 1919
2025
Q3
$1.17M Sell
20,498
-14,033
-41% -$831K ﹤0.01% 1957
2025
Q2
$1.91M Buy
34,531
+13,593
+65% +$637K ﹤0.01% 2163
2025
Q1
$915K Buy
20,938
+603
+3% +$26.3K ﹤0.01% 2348
2024
Q4
$875K Buy
20,335
+3,639
+22% +$164K ﹤0.01% 2423
2024
Q3
$746K Sell
16,696
-2,269
-12% -$93.8K ﹤0.01% 2516
2024
Q2
$730K Buy
+18,965
New +$723K ﹤0.01% 2513

Other funds holding DBD

UBS AM's DBD Position: Q2 2026 in Review

UBS AM increased its Diebold Nixdorf (DBD) stake by 22% in Q2 2026, buying an estimated $564K and bringing the position to 38,571 shares worth $3.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1825.

UBS AM first reported a position in DBD in Q2 2024 and has held it in 9 quarters since. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • UBS AM held 38,571 shares of Diebold Nixdorf worth $3.28M as of Q2 2026.
  • UBS AM bought 7,010 Diebold Nixdorf shares in Q2 2026, an estimated $564K.
  • Diebold Nixdorf made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1825 holding.
  • UBS AM first reported a position in Diebold Nixdorf in Q2 2024 and has held it in 9 quarters since.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.